NDAINTRAVENOUSEMULSIONPriority Review
Approved
Oct 2013
Lifecycle
LOE Approaching
Competitive Pressure
35/100
Data completeness
4/8 — Partial
Priority Review
CLINOLIPID 20% (olive oil and soybean oil) by Baxter is production. Approved for including term, preterm neonates, a source of calories and 4 more indications. First approved in 2013.
Drug data last refreshed 18h ago
Mechanism of Action
production. The most common mechanism of action for energy production derived from fatty acid metabolism is beta oxidation. Fatty acids are important for membrane structure and function, precursors for bioactive molecules (such as prostaglandins), and as regulators of gene expression.
Pharmacologic Class:
Lipid Emulsion
Indications (7)
Worked on CLINOLIPID 20% at Baxter? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.